Columbus Rx Inc - New York City, New York 10025

Columbus Rx Inc is categorized under in New York City, NY .

Business Name: Columbus Rx Inc
Address: 82 West 105th St, New York City, New York 10025
Phone Number: (973) 562-3548
Annual Revenue (USD): $100.000 to $499.999
Founding Year: 2008
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category:
SIC Code: 5912
NAICS Code: 446110
Share This Business:
Related Businesses: Quick R X - New York City, NY 10025
Duane Reade - New York City, NY 10025
Venus Pharmacy - New York City, NY 10025
Cvs/Pharmacy - New York City, NY 10025
Lerin Drug - New York City, NY 10025
Duane Reade - New York City, NY 10025
Walgreens - New York City, NY 10025
Third Avenue Drug Corp - New York City, NY 10025
Quick Rx Corp - New York City, NY 10025
909 Columbus Rx Corp - New York City, NY 10025
Venus Pharmacy & Beauty Corp - New York City, NY 10025
New Amsterdam Drug Mart Inc - New York City, NY 10025
Town Drug At Carnegie Inc - New York City, NY 10025
Nine Zero Nine Columbus Rx Crp - New York City, NY 10025
Duane Reade - New York City, NY 10025
Twenty Seven Broadway Drugs - New York City, NY 10025
Town Drug - New York City, NY 10025
Columbus Avenue Pharmacy - New York City, NY 10025
Duane Reade - New York City, NY 10025
Duane Reade - New York City, NY 10025

The company Columbus Rx Inc provides B2C services in the form of from its single location in New York. 1 to 4 employees work for Columbus Rx Inc, and the business now earns $100.000 to $499.999 per annum.

Columbus Rx Inc was launched in 2008 and is classified under SIC code and category 5912 , and NAICS number and grouping 446110 . To contact Columbus Rx Inc, please call with the phone number (973) 562-3548 or visit its single location at 82 West 105th St in New York City, New York 10025.

The location of the single location can also be found using the coordinates . Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.